Chevy Chase Trust Holdings Inc. cut its position in Humana Inc (NYSE:HUM) by 1.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 124,977 shares of the insurance provider’s stock after selling 2,360 shares during the quarter. Chevy Chase Trust Holdings Inc.’s holdings in Humana were worth $31,003,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. WFG Advisors LP raised its position in shares of Humana by 4.5% in the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after buying an additional 20 shares in the last quarter. Nordea Investment Management AB raised its position in shares of Humana by 1.0% in the 2nd quarter. Nordea Investment Management AB now owns 7,338 shares of the insurance provider’s stock valued at $1,766,000 after buying an additional 74 shares in the last quarter. Scotia Capital Inc. raised its position in shares of Humana by 4.8% in the 2nd quarter. Scotia Capital Inc. now owns 2,200 shares of the insurance provider’s stock valued at $529,000 after buying an additional 100 shares in the last quarter. Advantus Capital Management Inc raised its position in shares of Humana by 1.4% in the 3rd quarter. Advantus Capital Management Inc now owns 14,798 shares of the insurance provider’s stock valued at $3,605,000 after buying an additional 203 shares in the last quarter. Finally, Cadence Capital Management LLC raised its position in shares of Humana by 3.6% in the 3rd quarter. Cadence Capital Management LLC now owns 5,887 shares of the insurance provider’s stock valued at $1,434,000 after buying an additional 205 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Several brokerages have recently commented on HUM. Zacks Investment Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 19th. Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $221.00 target price for the company in a research report on Friday, January 12th. Credit Suisse Group began coverage on shares of Humana in a research report on Thursday, November 2nd. They issued a “neutral” rating and a $256.00 target price for the company. Cowen restated a “buy” rating and issued a $285.00 target price on shares of Humana in a research report on Wednesday, December 13th. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $230.00 target price on shares of Humana in a research report on Tuesday, December 5th. Ten research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $260.10.

In other Humana news, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the sale, the vice president now directly owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Brian P. Leclaire sold 1,679 shares of the business’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $245.97, for a total transaction of $412,983.63. Following the sale, the senior vice president now directly owns 9,888 shares in the company, valued at $2,432,151.36. The disclosure for this sale can be found here. Insiders have sold a total of 10,115 shares of company stock worth $2,501,627 over the last three months. Insiders own 0.80% of the company’s stock.

Shares of Humana Inc (NYSE:HUM) opened at $282.86 on Wednesday. Humana Inc has a 1-year low of $189.01 and a 1-year high of $283.93. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.35. The firm has a market cap of $40,410.00, a P/E ratio of 22.27, a price-to-earnings-growth ratio of 1.75 and a beta of 0.88.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The firm had revenue of $13.28 billion for the quarter, compared to analyst estimates of $13.41 billion. During the same period in the previous year, the firm posted $3.18 EPS. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. equities analysts predict that Humana Inc will post 11.63 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s payout ratio is 12.60%.

Humana declared that its Board of Directors has initiated a share buyback program on Thursday, December 14th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2018/01/24/chevy-chase-trust-holdings-inc-has-31-million-stake-in-humana-inc-hum.html.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.